Bloomage Biotechnology Corporation Limited — Investor Relations & Filings
About Bloomage Biotechnology Corporation Limited
Bloomage Biotechnology Corporation Limited is a global leader in the research, development, and production of hyaluronic acid and other bioactive substances. Utilizing advanced microbial fermentation and cross-linking technologies, the company provides high-quality raw materials for the pharmaceutical, cosmetic, and food sectors. Its product portfolio includes pharmaceutical-grade sodium hyaluronate, medical devices for ophthalmology and orthopedics, and aesthetic medicine solutions such as dermal fillers. Additionally, Bloomage develops and markets functional skin care brands and health foods. As the world's largest manufacturer of hyaluronic acid, the company maintains a vertically integrated industrial chain, focusing on biotechnology innovation to enhance human health and beauty. Its operations span global markets, serving diverse sectors with high-purity bioactive ingredients and finished consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 华熙生物关于控股股东增持公司股份计划公告 | 2025-08-07 | Chinese | |
| 华熙生物关于选举第三届董事会职工代表董事的公告 | 2025-07-16 | Chinese | |
| 华熙生物关于自愿披露公司通过美国FDA现场检查的公告 | 2025-07-09 | Chinese | |
| 华熙生物2024年年度权益分派实施公告 | 2025-07-07 | Chinese | |
| 北京市通商律师事务所关于华熙生物科技股份有限公司差异化分红事项之专项法律意见书 | 2025-07-07 | Chinese | |
| 华熙生物2024年年度报告（修订版） | 2025-06-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39082871 | 华熙生物关于控股股东增持公司股份计划公告 | 2025-08-07 | Chinese | ||
| 39082863 | 华熙生物关于选举第三届董事会职工代表董事的公告 | 2025-07-16 | Chinese | ||
| 39082853 | 华熙生物关于自愿披露公司通过美国FDA现场检查的公告 | 2025-07-09 | Chinese | ||
| 39082848 | 华熙生物2024年年度权益分派实施公告 | 2025-07-07 | Chinese | ||
| 39082844 | 北京市通商律师事务所关于华熙生物科技股份有限公司差异化分红事项之专项法律意见书 | 2025-07-07 | Chinese | ||
| 39082833 | 华熙生物2024年年度报告（修订版） | 2025-06-30 | Chinese | ||
| 39082830 | 华熙生物关于获得政府补助的公告 | 2025-06-30 | Chinese | ||
| 39082825 | 致同会计师事务所（特殊普通合伙）关于华熙生物科技股份有限公司2024年年度报告的信息披露监管问询函中有关财务会计问题的专项说明 | 2025-06-30 | Chinese | ||
| 39082605 | 华熙生物关于2024年年度报告的信息披露监管问询函的回复公告 | 2025-06-30 | Chinese | ||
| 39082602 | 北京市通商律师事务所关于华熙生物科技股份有限公司2024 年年度股东大会的法律意见书 | 2025-06-11 | Chinese | ||
| 39082592 | 华熙生物关于公司董事会完成换届选举暨聘任高级管理人员的公告 | 2025-06-11 | Chinese | ||
| 39082584 | 华熙生物2024年年度股东大会决议公告 | 2025-06-11 | Chinese | ||
| 39082576 | 华熙生物2024年年度股东大会资料 | 2025-05-29 | Chinese | ||
| 39082570 | 华熙生物关于召开2024年年度股东大会的通知 | 2025-05-20 | Chinese | ||
| 39082557 | 华熙生物科技股份有限公司利润分配管理制度（2025年5月修订） | 2025-05-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Bloomage Biotechnology Corporation Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bloomage Biotechnology Corporation Limited (id: 58370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.